Trial intelligence / Profile preview

Na-GST-1/Alhydrogel with or without CpG 10104 in Healthy Adults

NCT02143518Phase 1Completed

Sponsor
Baylor College of Medicine
Start
Oct 2014
Primary completion
Jun 2016
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of Necator americanus Glutathione-S-Transferase-1 in hookworm infection (3 arms), sponsored by Baylor College of Medicine. Primary endpoint: Vaccine-related Adverse Events at Day 470. Started Oct 2014; status: completed.

02

Drugs

Necator americanus Glutathione-S-Transferase-1
03

Conditions

hookworm infection

Beyond the preview

Go deeper on NCT02143518.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02143518.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call